Drugs / Inactivated Influenza Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02508194 Background | Sep 2015 → Sep 2016 | respiratory syncytial virus infectious disease | MedImmune LLC | Terminated | Missed primary Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated Influenza Vaccine | “Placebo + Inactivated Influenza Vaccine (IIV)” NCT02508194 ↗ |
| Known as | IIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02508194 ↗ |
| Modality | Vaccine | “Marketed Inactivated Influenza Vaccine” NCT02508194 ↗ |